<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>国广有话说 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-28T23:26:39+08:00</updated>
  <subtitle>立足于客观公正，挖掘发现医药企业价值投资机会</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>九洲药业(603456)：CDMO跨越式成长，业绩持续高增【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/ayg8AIXeD32JR6hiOZaSmQ</id>
    <link href="https://mp.weixin.qq.com/s/ayg8AIXeD32JR6hiOZaSmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>爱美客三季报点评：Q3业绩超预期，净利率水平再提升【东吴医药&amp;社服零售】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/a0PzKsNf2kMoYRP-BAJKhA</id>
    <link href="https://mp.weixin.qq.com/s/a0PzKsNf2kMoYRP-BAJKhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昊海生科三季报点评：业绩逐季恢复，Q3眼科骨科实现双位数增长【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/cYlyi8B11VDbCO2QeWDpig</id>
    <link href="https://mp.weixin.qq.com/s/cYlyi8B11VDbCO2QeWDpig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信邦制药三季报点评：经营业绩逐季恢复，战略发展医疗服务【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/nmSFvIiCKZFCSZNEcEawXg</id>
    <link href="https://mp.weixin.qq.com/s/nmSFvIiCKZFCSZNEcEawXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昂利康三季报点评：Q3净利超预期，公司加速步入增长期【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/M0pE_y0AvEfi6ESEei1zjw</id>
    <link href="https://mp.weixin.qq.com/s/M0pE_y0AvEfi6ESEei1zjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>金域医学三季报点评：Q3新冠维持高贡献，公司业绩持续高增【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/P7N4K8Li_PvRgUY4dnmorA</id>
    <link href="https://mp.weixin.qq.com/s/P7N4K8Li_PvRgUY4dnmorA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南微医学三季报点评：Q3业绩显著反弹，疫情不改公司长期逻辑【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/L9vxnHiHWIqOgucD-oxKNg</id>
    <link href="https://mp.weixin.qq.com/s/L9vxnHiHWIqOgucD-oxKNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>爱博医疗三季报点评：Q3业绩加速增长，看好公司中长期发展【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/ixjfXPSR_om52V-hsRCwuw</id>
    <link href="https://mp.weixin.qq.com/s/ixjfXPSR_om52V-hsRCwuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>理邦仪器三季报点评：Q3持续高增长，疫情加快公司发展步伐【东吴医药朱国广团队】</title>
    <updated>2020-10-27T13:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/dPFgehneCEsUkCUyB_Cj1Q</id>
    <link href="https://mp.weixin.qq.com/s/dPFgehneCEsUkCUyB_Cj1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东诚药业三季报点评：Q3业绩符合预期，核药逐渐恢复【东吴医药朱国广团队】</title>
    <updated>2020-10-27T13:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/bsLWUl7UTF0NMZKyG7R2qw</id>
    <link href="https://mp.weixin.qq.com/s/bsLWUl7UTF0NMZKyG7R2qw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧普康视三季报点评：Q3业绩高增长，未来成长空间广阔【东吴医药朱国广团队】</title>
    <updated>2020-10-27T13:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/C8O_-9oEXmRGyAZ5XOd3MQ</id>
    <link href="https://mp.weixin.qq.com/s/C8O_-9oEXmRGyAZ5XOd3MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>爱尔眼科三季报点评：经营业绩逐季向好，利润率水平有所提升【东吴医药朱国广团队】</title>
    <updated>2020-10-27T13:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/1m-nGPPY4LDqdtnpsbgWdg</id>
    <link href="https://mp.weixin.qq.com/s/1m-nGPPY4LDqdtnpsbgWdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>通策医疗三季报点评：公司经营逐季向好，人才储备与蒲公英计划稳步推进【东吴医药朱国广团队】</title>
    <updated>2020-10-27T13:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/rABYcjaPj2kMYlNQMNKZsg</id>
    <link href="https://mp.weixin.qq.com/s/rABYcjaPj2kMYlNQMNKZsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>长春高新三季报点评：业绩符合预期，疫苗板块加速放量【东吴医药朱国广团队】</title>
    <updated>2020-10-27T13:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/U1yBU0KvRB0p_LzJ_Y4oow</id>
    <link href="https://mp.weixin.qq.com/s/U1yBU0KvRB0p_LzJ_Y4oow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华熙生物(688363)：三位一体，产业链贯通的医美大玩家！【东吴医药&amp;零售社服】</title>
    <updated>2020-10-26T23:29:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/cqPK6g_LM6aqXMOLqFukeg</id>
    <link href="https://mp.weixin.qq.com/s/cqPK6g_LM6aqXMOLqFukeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三季报业绩符合预期，医药为何不涨反跌？【东吴医药朱国广团队|1025周报】</title>
    <updated>2020-10-25T16:55:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/HDxIRCP73WX50lP5Dd2AHg</id>
    <link href="https://mp.weixin.qq.com/s/HDxIRCP73WX50lP5Dd2AHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>凯莱英三季报点评：订单交付产能释放，Q3业绩稳步高增【东吴医药朱国广团队】</title>
    <updated>2020-10-25T16:55:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/uV-HsjrIv0zhAPzufTL8gQ</id>
    <link href="https://mp.weixin.qq.com/s/uV-HsjrIv0zhAPzufTL8gQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“横看成岭侧成峰”——“秒懂”全球创新药系列研究之靶点掘金（第01期：TIGIT）</title>
    <updated>2020-10-24T17:37:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/jlhfVh_NoyzDdh0J73Sn9Q</id>
    <link href="https://mp.weixin.qq.com/s/jlhfVh_NoyzDdh0J73Sn9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>爱美客(300896)：“颜值”经济时代红利，医美龙头未来可期！【东吴医药&amp;社服零售】</title>
    <updated>2020-10-23T10:07:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/wFC5tCte7hrxFa4Ukl7bpg</id>
    <link href="https://mp.weixin.qq.com/s/wFC5tCte7hrxFa4Ukl7bpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博瑞医药三季报点评：Q3业绩超预期，原料药及制剂放量加速【东吴医药朱国广团队】</title>
    <updated>2020-10-23T10:07:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/t9B3B10nMIGOChC4_clhgQ</id>
    <link href="https://mp.weixin.qq.com/s/t9B3B10nMIGOChC4_clhgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>